What are you looking for?
All Filters
Therapeutic Area
Therapeutic Area
Date Published
Date published
Group 2362.png

 

Voltaren 75mg/3ml ampoules

 

Voltaren® 75mg/3mL ampoule is indicated for 
Post-traumatic and post-operative pain, inflammation and swelling.1

 

Dosage

Group 2451.png

 

Following i.m. injection of 75 mg diclofenac, mean peak plasma concentrations of 2.5 μg/ml are attained after approximately 20 minutes1

Group 2356.png
Frame 427318830.png

 

Efficacy

 

Postoperative pain was significantly (P < 0.05) milder in patients receiving Voltaren® IV vs placebo.2

The incidence of postoperative pain in the oral region in patients undergoing oral surgery or restorative dentistry under isoflurane anaesthesia preceded by diclofenac sodium or saline

 

Frame 427318833.png
Study Design

For Voltaren® Amp. Abbreviated prescribing information

PDF
View

References

  1. Voltaren 75mg/3ml solution for Injection Egyptian Drug Authority (EDA) approved insert leaflet. Date of approval: 10/02/2025. 

  2. Valanne J, Korttila K, Ylikorkala O. Intravenous diclofenac sodium decreases prostaglandin synthesis and postoperative symptoms after general anaesthesia in outpatients undergoing dental surgery. Acta anaesthesiologica scandinavica. 1987 Nov;31(8):722-7.

Approved by Egyptian Drug Authority: HF0082OA4733/082025. Invalidation date: 28/08/2027.
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at: www.edaegypt.gov.eg

Dentist QR Code

HF0082OA4733/082025
28/08/2027

 

        

Adverse Events Reporting

We encourage using the following Electronic reporting tool for reporting into the safety database directly:
If the electronic reporting tool is not working - please use the following: https://www.report.novartis.com
1 - Generic Mailbox: [email protected]
2 - CISCO: +20 2 2 2861000: Press 3 for Adverse Events Reporting